OMEROS CORP 10-K

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES Market Information Our common stock is traded on The Nasdaq Global Market under the symbol “OMER.” Holders As of February 24, 2022, there were approximately 62,726,515 shares of our common stock outstanding, which were held by 85 holders of record. Dividends We have never declared or paid any cash dividends on our capital stock. We expect to retain all available funds and future earnings to fund the development and growth of our business and we do not anticipate paying any cash dividends in the foreseeable future. Recent Sales of Unregistered Securities We did not sell any equity securities that were not registered under the Securities Act during the fiscal year ended December 31, 2021. Stock Performance Graph The following graph compares the cumulative total shareholder return for our common stock (OMER), the Nasdaq Biotechnology Index (NBI) and the Nasdaq U.S. Benchmark TR Index (NQUSBT) for the period beginning December 31, 2016 and ending December 31, 2021. This graph assumes that $100 was invested on December 31, 2016 in our common stock, the Nasdaq Biotechnology Index and the Nasdaq U.S. Benchmark TR Index. It also assumes that 45 Table of Contents any dividends were reinvested. The data shown in the following graph are not necessarily indicative of future stock price performance. Comparison of 5 Year Cumulative Return Assumes Initial Investment of $100 The foregoing information shall not be deemed to be “soliciting material” or to be “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to liability under that Section. In addition, the foregoing information shall not be deemed to be incorporated by reference into any of our filings under the Exchange Act or the Securities Act, except to the extent that we specifically incorporate this information by reference. ​ ITEM 6. [RESERVED] ​